Recombinant Mouse Ccl12 Protein，His

CCL12, also known as MCP-4 (Monocyte Chemoattractant Protein-4), is a member of the CC chemokine family, primarily involved in the recruitment of monocytes, eosinophils, and memory T cells to sites of inflammation. The research surrounding CCL12 recombinant protein has gained significance due to its potential role in various pathological conditions, including allergic diseases, asthma, and cancer. Elevated CCL12 levels are often observed in inflamed tissues, indicating its involvement in immune responses and tissue remodeling. Studies have shown that CCL12 interacts with its receptor CCR2, triggering a cascade of cellular responses essential for orchestrating the immune system's activities. The synthesis of CCL12 as a recombinant protein allows for detailed investigations into its biological functions, receptor interactions, and therapeutic applications. By employing recombinant DNA technology, researchers can produce CCL12 in a purified form for use in various experimental models, facilitating a deeper understanding of its role in both normal physiology and disease states. Additionally, the exploration of CCL12 antagonists or monoclonal antibodies targeting this chemokine represents a promising avenue for the development of novel therapeutic strategies aimed at modulating immune responses and treating inflammatory disorders. With the increasing interest in chemokines and their pathways, CCL12 serves as a crucial molecule for understanding the complexities of immune regulation and inflammatory processes, paving the way for innovative treatment approaches.